BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 29653575)

  • 1. Enhanced stability of a chimeric hepatitis B core antigen virus-like-particle (HBcAg-VLP) by a C-terminal linker-hexahistidine-peptide.
    Schumacher J; Bacic T; Staritzbichler R; Daneschdar M; Klamp T; Arnold P; Jägle S; Türeci Ö; Markl J; Sahin U
    J Nanobiotechnology; 2018 Apr; 16(1):39. PubMed ID: 29653575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.
    Pascual E; Mata CP; Gómez-Blanco J; Moreno N; Bárcena J; Blanco E; Rodríguez-Frandsen A; Nieto A; Carrascosa JL; Castón JR
    J Virol; 2015 Mar; 89(5):2563-74. PubMed ID: 25520499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.
    Hassebroek AM; Sooryanarain H; Heffron CL; Hawks SA; LeRoith T; Cecere TE; Stone WB; Walter D; Mahsoub HM; Wang B; Tian D; Ivester HM; Allen IC; Auguste AJ; Duggal NK; Zhang C; Meng XJ
    J Med Virol; 2023 Feb; 95(2):e28503. PubMed ID: 36655751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of chimeric hepatitis B core particles into liver cells.
    Lee KW; Tey BT; Ho KL; Tan WS
    J Appl Microbiol; 2012 Jan; 112(1):119-31. PubMed ID: 21992228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability and morphology comparisons of self-assembled virus-like particles from wild-type and mutant human hepatitis B virus capsid proteins.
    Newman M; Suk FM; Cajimat M; Chua PK; Shih C
    J Virol; 2003 Dec; 77(24):12950-60. PubMed ID: 14645551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles.
    Chen J; Zhang C; Zhou Y; Zhang X; Shen C; Ye X; Jiang W; Huang Z; Cong Y
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification of His-tagged hepatitis B core antigen from unclarified bacterial homogenate using immobilized metal affinity-expanded bed adsorption chromatography.
    Yap WB; Tey BT; Alitheen NB; Tan WS
    J Chromatogr A; 2010 May; 1217(21):3473-80. PubMed ID: 20388569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient Production of Chimeric Hepatitis B Virus-Like Particles Bearing an Epitope of Hepatitis E Virus Capsid by Transient Expression in
    Zahmanova G; Mazalovska M; Takova K; Toneva V; Minkov I; Peyret H; Lomonossoff G
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33477348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered fusion of allergen and viral-like particle induces a more effective allergen-specific immune response than a combination of them.
    Sani MZ; Bargahi A; Momenzadeh N; Dehghani P; Moghadam MV; Maleki SJ; Nabipour I; Shirkani A; Akhtari J; Hesamizadeh K; Heidari S; Omrani F; Akbarzadeh S; Mohammadi M
    Appl Microbiol Biotechnol; 2021 Jan; 105(1):77-91. PubMed ID: 33215260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.
    Feng X; Liu H; Chu X; Sun P; Huang W; Liu C; Yang X; Sun W; Bai H; Ma Y
    Acta Biomater; 2019 Dec; 100():316-325. PubMed ID: 31542504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis core antigen produced in Escherichia coli: subunit composition, conformational analysis, and in vitro capsid assembly.
    Wingfield PT; Stahl SJ; Williams RW; Steven AC
    Biochemistry; 1995 Apr; 34(15):4919-32. PubMed ID: 7711014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An N-terminal extension to the hepatitis B virus core protein forms a poorly ordered trimeric spike in assembled virus-like particles.
    McGonigle R; Yap WB; Ong ST; Gatherer D; Bakker SE; Tan WS; Bhella D
    J Struct Biol; 2015 Feb; 189(2):73-80. PubMed ID: 25557498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of a peptide mimicking neutralization epitope of hepatitis E virus with phage peptide display technology.
    Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS
    World J Gastroenterol; 2004 Jun; 10(11):1583-8. PubMed ID: 15162530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like Particles.
    Tang S; Xuan B; Ye X; Huang Z; Qian Z
    Sci Rep; 2016 May; 6():25741. PubMed ID: 27170066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation by alkaline treatment and detailed characterisation of empty hepatitis B virus core particles for vaccine and gene therapy applications.
    Strods A; Ose V; Bogans J; Cielens I; Kalnins G; Radovica I; Kazaks A; Pumpens P; Renhofa R
    Sci Rep; 2015 Jun; 5():11639. PubMed ID: 26113394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absolute Quantification of Hepatitis B Core Antigen (HBcAg) Virus-like Particles and Bound Nucleic Acids.
    Valentic A; Böhner N; Hubbuch J
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification of E. coli-expressed HIS-tagged hepatitis B core antigen by Ni2+ -chelate affinity chromatography.
    Wizemann H; von Brunn A
    J Virol Methods; 1999 Feb; 77(2):189-97. PubMed ID: 10092142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.